When compared to those with G/G genotype, NAFLD patients carrying G/A+A/A genotypes at APOC3 rs2070667 demonstrated statistically lowered levels of TGs (TG 54 : 7, TG 54 : 8, and TG 54 : 9), whereas obvious higher levels of Cer (Cer 42 : 1; 2), DG (DG 36 : 4), and PCO (PCO 38 : 4 and PCO 40 : 4) (Table 2). This evidence concerns the gene CBLN1 and metabolic dysfunction-associated steatotic liver disease.